drugset
drugset / Trial / NCT07865871

Role of Inhaled Polymyxin as an Adjunct to Intravenous Therapy in Multidrug Resistant Ventilator-associated Pneumonia in Stroke Patients

NCT07865871 ↗

Phase 0 Not yet recruiting 78 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study investigates whether adjunctive inhaled colistin enhances clinical recovery and microbiological clearance in multidrug resistant ventilator-associated pneumonia in stroke patients

Timeline

Start
2026-10-10
Primary completion
2027-10-01
Completion
2027-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 2.5 mg/kg Inhaled
Subject Colistin Other / unclassified 500000 iu Inhaled

Indications

bacterial pneumonia